Viral HS "Hacks" That Are Actually Hurting Your Skin
Just because it went viral doesn't mean it's safe for your skin. Here's why these popular HS trends do more harm than good.
Blog
Notes on new research, guidelines and clinical practice in dermatology and internal medicine.

Just because it went viral doesn't mean it's safe for your skin. Here's why these popular HS trends do more harm than good.

A positive ANA test is a starting point for investigation, not a diagnosis of lupus. What this screening test measures, why healthy people can test positive, and what to do next.

Late-breaking Phase 2b results for tulisokibart (MK-7240), an investigational TL1A-blocking antibody for adults with moderate-to-severe hidradenitis suppurativa.

For up to 30% of people living with psoriasis, the condition extends beneath the skin to the joints. Five early warning signs of psoriatic arthritis, and what to do next.

54-week results from the STOP-HS1 and STOP-HS2 Phase 3 trials of povorcitinib, an investigational once-daily oral JAK1 inhibitor for moderate-to-severe hidradenitis suppurativa.

The FDA approved icotrokinra (Icotyde), a once-daily tablet that blocks the IL-23 receptor, for adults and adolescents with moderate-to-severe plaque psoriasis.

Rheum-derm conditions are internally systemic yet externally visible. An honest look at their emotional and social impact, and practical ways to protect your well-being.

Why I'm starting this blog, and what I plan to write about at the intersection of internal medicine and dermatology.

Why research matters for patients, and a list of my published papers on neutrophils and autoimmune disease.

No diet can cure an autoimmune disease or replace your medications, but the foods you eat every day play an important supporting role. An easy-to-follow, evidence-based guide.

A consistent, science-backed skin care routine reduces scaling, relieves itch, helps medications work better, and helps prevent new plaques. Here is how to build one.